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Dear Editor, 
Chlorogenic acid (CGA; (IS,3R,4R.5R)-3-{[(2Z)-3-(3,4-dihydroxyphenyl)prop-2-
enoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid) is an ester formed from caffeic acid 
and quinic acid and works as an intermediate in lignin biosynthesis (Abrankó and Clifford, 
2017). CGA, one of the most abundant polyphenol compounds in the human diet, consists of a 
group of phenolic secondary metabolites isolated from the leaves and fruits of dicotyledonous 
plants, which is an important component of coffee. CGA has the capacity to manipulate the 
taste of coffee by modifying astringent, sweet, and sour tastes, which change with the concen-
tration (Tajik et al., 2017). 
CGAs are biosynthetically derived from phenylalanine following the phenylpropanoid re-
action pathway, which is responsible for the synthesis of several important compounds, like 
flavonoids, isoflavonoid phytoalexins, coumarins, and lignin (Clifford et al., 2017). There are 
three possible pathways projected from the p-coumaroyl CoA. Each pathway engages with the 
same types of enzymatic reactions, such as esterification and hydroxylation (Zhao et al., 2018). 
These compounds protect plant tissues from damage by oxidative stress, pathogen infection, 
and wounds. They are also used to mediate animal health (Telles et al., 2017). CGA has a 
broader range of potential biological properties for health benefits, which might provide non-
pharmacological and non-invasive hepatoprotective, antioxidant, anti-diabetic, antimicrobial, 
anticarcinogenic, anti-inflammatory, and anti-obesity strategies (Maalik et al., 2016; Santana-
Gálvez et al., 2017; Tošović et al., 2017; Naveed et al., 2018). Here, we summarize recent 
literature on the effects of CGAs on different features of health (Table 1).  
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Table 1: Recent studies of the biological and pharmacological activities of chlorogenic acid 
Key findings Reference 
A recent study has shown that CGA can effectively act against Al (III)-stimulated 
cytotoxicity in RAW264.7 cells through the mitogen-activated protein kinase 
(MAPK)/Akt-mediated caspase pathways.  
Cheng et al., 
2019 
By suppressing the activation of pro-inflammatory and apoptotic signaling path-
ways, CGA may be very effective against inflammation and attenuating colitis 
severity. 
Vukelić et al., 
2018 
CGA, which might be used as a potential therapeutic compound for bovine mas-
titis, had anti-inflammatory activity by inhibiting nuclear factor kappa beta (NF-
κB) activation. 
Gao et al., 2018 
After treatment with CGA, liver injury and insulin resistance could be relieved by 
suppressing autophagy through the inactivation of the C-Jun N-terminal kinase 
pathway in a non-alcoholic fatty liver disease (NAFLD) rat model. Based on this 
finding, CGA could potentially be used for the treatment of NAFLD. 
Yan et al., 2018 
 
Crude extract of Aster koraiensis acted as a potent antiangiogenic agent. The 
antiangiogenic activity might be attributable to the bioactive component, CGA. 
Kim et al., 2018 
 
CGA, when treated with Regorafenib, improved the anti-cytotoxicity action of 
Regorafenib in hepatocarcinoma (HCC) cells. This combined treatment as a 
drug might be a safe and more effective option in HCC therapy. 
Refolo et al., 
2018 
Continuously taking CGA for a period of 6-months improved attention, execu-
tive, and memory functions in the elderly who complained of subjective memory 
loss. 
Kato et al., 2018  
CGAs improve quality of coffee beverages by decreasing the concentration of 5-
O-CGA, while maintain the aroma and taste profile. This might be useful to peo-
ple with sensitive stomachs. 
Siebert et al., 
2018 
CGA has a significant antidepressant response in sleep-deprived rats. The 
mechanism of action of CGA may involve the regulation of abnormal pathways, 
including metabolism of nicotinate and nicotinamide; metabolism of glyoxylate 
and dicarboxylate; metabolism of glycine, serine, and threonine; and metabo-
lism of arginine and proline. 
Ma et al., 2018 
CGA stimulates bacterial apoptosis in E. coli and the depletion of intracellular 
ROS (reactive oxygen species), which might regulate the progression of bacte-
rial apoptosis-like death. 
Lee and Lee, 
2018 
Dietary supplementation with CGA enhances the growth performance and re-
duces the diarrhea incidences of the weaned pigs. It is suggested that CGA im-
proved the antioxidant capacity and enhanced the intestinal digestion and ab-
sorption function. 
Chen et al., 2018 
Semen was effectively stored in 3.2 mg/mL of CGA at 15 °C for up to 24 hr. 
From this finding, it can be assumed that semen could be stored for longer du-
rations if the CGA concentration increased (6.0 mg/ml or more). 
Pereira et al., 
2018 
CGA, combined with phospholipid complex (PC), improved the post-myocardial 
infarction inflammatory response in aging hearts, making PC a promising candi-
date for the clinical development of CGA. 
Li et al., 2018 
CGA assuaged hepatotoxicity and cholestasis by reducing the uptake and syn-
thesis of bilirubin and bile acids, and finally enhancing the metabolism and efflux 
of bilirubin and bile acids. 
Zhu et al., 2018 
By increasing cyclic adenosine monophosphate (cAMP) levels via adenylyl 
cyclase activation, CGA significantly reduced the carbachol-induced contrac-
tions of the mouse urinary bladder. 
Kaneda et al., 
2018 
CGA reduces human lens epithelial cells (hLECs) apoptosis and protects lenses 
from opacity induced by H2O2 via the BCL2 (B-cell lymphoma 2) associated X 
apoptosis regulator (Bax)/ BCL2 apoptosis regulator (Bcl-2) signaling pathway. 
CGA shows effective defenses against oxidative stress, which could treat a vari-
ety of diseases in clinical practice. 
Song et al., 2018 
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Key findings Reference 
CGA treatment could inhibit the retinal neoangiogenesis during diabetic reti-
nopathy by nullifying high glucose (HG)-induced hypoxia-inducible factor 1-al-
pha (HIF-1α)-mediated paracrine vascular endothelial growth factor (VEGF) ex-
pression in microglia cells and reducing VEGF-induced angiogenesis in retinal 
endothelial cells. 
Mei et al., 2018 
CGA is considered as a therapeutic agent for the treatment of diabetic nephro- 
pathy, showing antioxidant and anti-inflammatory effects that are activated via 
the modulation of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2)/ 
heme oxygenase-1 (HO-1) and NF-ĸB pathways. 
Bao et al., 2018 
CGA prevents acetaminophen (APAP)-induced hepatotoxicity through the Nrf2 
antioxidative signaling pathway by blocking the binding of Nrf2 to its deterrence 
protein, Keap1. Extracellular regulated protein kinase (ERK) 1/2 play a vital role 
in regulating CGA-induced Nrf2 transcriptional activation. CGA could be utilized 
as a promising therapeutic agent for the detoxification of APAP-induced hepato-
toxicity. 
Wei et al., 2018 
CGA influences the expression of apoptosis genes related to the oxidative 
stress and p38 MAP-dependent pathways and the expression of genes encod-
ing stem cell markers. CGA may show polyphenolic anti-cancer effects through 
the consumption of vegetables and fruits. 
Yamagata et al., 
2018 
By reducing the apoptosis of neuronal cells, CGA mitigates the neuronal dam-
age induced in alcohol exposed neonatal rat. 
Guo and Li, 2017
CGA has the potential to relieve liver fibrosis through the miR-21-regulated 
TGF-β1/Smad7 signaling pathway, which suggests that CGA could act as a new 
anti-fibrosis agent against liver fibrosis. 
Yang et al., 2017 
By administering appropriate amounts of myricetin-3-O-β-rhamnoside and CGA 
synergistically, the fibroblastic and remodeling phases of wound repair are ac-
celerated. 
Moghadam et 
al., 2017 
CGA controls several mechanisms of action for the development of highly valu-
able therapeutics for metabolic diseases, such as type 2 diabetes. 
Sanchez et al., 
2017 
CGA shows antifungal activity against phytopathogenic fungi relevant to horti-
culture and agriculture, suggesting potential biofungicides activity in CGA-en-
riched wastes and by-products. 
Martínez et al., 
2017 
CGA can modify the gut microbial community structure in the intestines, exhibit-
ing lower intestinal and systemic inflammation, and also enhancing the course 
of the dextran sulfate sodium-induced colitis, which is linked to a proportional in-
crease in Akkermansia. 
Zhang et al., 
2017 
CGA has similar responses to caffeic acid. In vitro maturation (IVM) with 50 μM 
of CGA is particularly useful to the in vitro production (IVP) of porcine embryos; 
50 μM of CGA prevents oocytes from DNA damage induced by oxidative stress. 
The addition of CGA to the maturation medium has the potential to enhance the 
porcine IVP system. 
Nguyen et al.,  
2017 
CGA prevents the interleukin (IL)-1β-induced inflammatory response, through 
the NF-κB signaling pathway. CGA could be a suitable candidate for the treat-
ment of osteoarthritis. 
Liu et al., 2017 
CGA prevents focal cerebral ischemia reperfusion injury in a rat model by main-
taining the inflammatory factor, hypoxia factor, and nerve growth factor. 
Miao et al., 2017 
CGA prevents the progression of hepatocellular carcinoma via multiple path-
ways. CGA could be an effective chemopreventive agent for hepatocellular car-
cinoma. 
Yan et al., 2017 
CGA retrained benign prostatic hyperplasia in model animals, and this mecha-
nism could protect typeⅡ5-alpha reductase activity. 
Huang et al., 
2017 
Consumption of CGA for a period of 5 days significantly enhances fat oxidation 
during sleep, indicating that beverages containing CGA may be useful to lessen 
body fat and protect from obesity. Taking CGA also minimizes sleep latency 
without any adverse effects on sleep quality. 
Park et al., 2017 
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Key findings Reference 
CGA can be used as a neuraminidase blocker to prevent influenza A virus both 
in cellular and animal models, revealing a potential utility for the treatment of the 
influenza virus infection. 
Ding et al., 2017 
A self-microemulsifying drug delivery system (SMEDDS) promotes the oral bio-
availability of CGA by enhancing its absorption and slowing the metabolism of 
absorbed CGA by changing its distribution from the liver to the kidney. 
SMEDDS is an increasingly utilized carrier for the oral delivery of CGA. 
Chen et al., 2017 
CGA significantly protects mice from Con A-induced hepatitis by reducing the 
activation of Toll-like receptor (TLR) 4 signaling. This response lowers the ex-
pression of adhesion molecules and enhances the infiltration and activation of 
hepatic leukocytes and the production of pro-inflammatory cytokines. 
Yuan et al., 2017 
CGA reduces glioma growth by enhancing M1-polarized macrophages and pro-
tecting M2 phenotypic macrophages as a potential therapeutic approach. 
Xue et al., 2017 
CGA promotes potassium efflux, resulting in an apoptotic volume decrease 
(AVD) and G2/M cell cycle arrest in Candida albicans. Thus, potassium efflux 
via potassium channels improves CGA-induced apoptosis, stimulating several 
apoptotic processes. 
Yun and Lee, 
2017 
CGA prevents Iso-induced vascular smooth muscle cells (VSMC)  damage 
through the suppression of ROS generation. This finding suggests that CGA 
could be a novel treatment for vascular diseases. 
Wang et al., 
2016 
CGA prevents both ɑ-naphthylisothiocyanate-induced intrahepatic cholestasis 
and liver injury. This protective mechanism is modulated through the down-reg-
ulation of signal transducer and activator of transcription 3 (STAT3) and NF-κB 
signaling. 
Tan et al., 2016 
CGA mitigates the oxidative stress in streptozocin-induced diabetic nephropathy 
(DN) rats. Its molecular mechanism could prevent the endoplasmic reticulum-
stress response in DN. 
Ye et al., 2016 
CGA is a novel therapeutic agent for preventing inflammatory hyperplasia of the 
synovium by enhancing synoviocyte apoptosis in patients with rheumatoid ar-
thritis. 
Lou et al., 2016 
CGA significantly increases hepatic lipid dysregulation in rats by activating fatty 
acid metabolism enzymes, enhancing AMP-activated protein kinase activation, 
and modulating levels of hepatic fatty acids. 
Zhou et al., 2016 
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